Warning: Illegal string offset 'enable' in /home/redhothe/public_html/wp-content/plugins/conditional-widgets/logic.php on line 171
RED HOT Contributors


Intercept hits regulatory snag at FDA, likely delaying NASH drug’s approval

CREDIT: This post was originally published on this site

The company said that the agency had requested additional data for obeticholic acid and thus pushed the upcoming advisory committee meeting back from June 9, thereby delaying its decision on approval, which had also been scheduled for June 26.



We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast